Searching across hundreds of databases

Our searching services are busy right now. Your search will reload in five seconds.

X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

Role of Macrophages and Plasminogen Activator Inhibitor-1 in Delayed Bone Repair in Diabetic Female Mice.

Endocrinology | 2018

Delayed fracture healing is a clinical problem in diabetic patients. However, the mechanisms of diabetic delayed bone repair remain unknown. Here, we investigate the role of macrophages in diabetic delayed bone repair after femoral bone injury in streptozotocin (STZ)-treated and plasminogen activator inhibitor-1 (PAI-1)-deficient female mice. STZ treatment significantly decreased the numbers of F4/80-positive cells (macrophages) but not granulocyte-differentiation antigen-1-positive cells (neutrophils) at the damaged site on day 2 after femoral bone injury in mice. It significantly decreased the messenger RNA (mRNA) levels of macrophage colony-stimulating factor, inducible nitric oxide synthase (iNOS), interleukin (IL)-6, and CD206 at the damaged site on day 2 after bone injury. Moreover, STZ treatment attenuated a decrease in the number of hematopoietic stem cells in bone marrow induced by bone injury. On the other hand, PAI-1 deficiency significantly attenuated a decrease in the number of F4/80-positive cells induced by STZ treatment at the damaged site on day 2 after bone injury in mice. PAI-1 deficiency did not affect the mRNA levels of iNOS and IL-6 in F4/80- and CD11b-double-positive cells from the bone marrow of the damaged femurs decreased by diabetes in mice. PAI-1 deficiency significantly attenuated the phagocytosis of macrophages at the damaged site suppressed by diabetes. In conclusion, we demonstrated that type 1 diabetes decreases accumulation and phagocytosis of macrophages at the damaged site during early bone repair after femoral bone injury through PAI-1 in female mice.

Pubmed ID: 29534207 RIS Download

Publication data is provided by the National Library of Medicine ® and PubMed ®. Data is retrieved from PubMed ® on a weekly schedule. For terms and conditions see the National Library of Medicine Terms and Conditions.

This is a list of tools and resources that we have found mentioned in this publication.


SDF-1 (C-19) (antibody)

RRID:AB_2088173

This unknown targets Raised against a peptide mapping at the c-terminus of Human SDF-1

View all literature mentions

Sp7 / Osterix antibody (antibody)

RRID:AB_2194492

This polyclonal targets SP7

View all literature mentions

RAT ANTI MOUSE F4/80:RPE (antibody)

RRID:AB_322048

This monoclonal targets RAT ANTI MOUSE F4/80:RPE

View all literature mentions

Lineage Antibody Cocktail, with Isotype Control (antibody)

RRID:AB_10612020

This unknown targets Lineage Cocktail with Isotype Control

View all literature mentions

BV711 Rat Anti-Mouse CD117 (antibody)

RRID:AB_2722510

This monoclonal targets CD117

View all literature mentions

CD34 (antibody)

RRID:AB_1727471

This monoclonal targets CD34

View all literature mentions

Neutrophil (Ly-6G/-6C) (antibody)

RRID:AB_303154

This monoclonal targets Highly purified BALB/c mouse Neutrophils, The antibody NIMP-R14 is highly specific for murine Ly-6G and Ly-6C.

View all literature mentions

GraphPad Prism (software resource)

RRID:SCR_002798

Statistical analysis software that combines scientific graphing, comprehensive curve fitting (nonlinear regression), understandable statistics, and data organization. Designed for biological research applications in pharmacology, physiology, and other biological fields for data analysis, hypothesis testing, and modeling.

View all literature mentions